|
MRPL39 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.13969977689044E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6747999997957E-07 |
| Normal-vs-Stage2 |
4.421600E-02 |
| Normal-vs-Stage3 |
1.26019999990845E-08 |
| Normal-vs-Stage4 |
5.09649988877925E-10 |
| Stage1-vs-Stage2 |
5.751000E-01 |
| Stage1-vs-Stage3 |
5.395700E-02 |
| Stage1-vs-Stage4 |
1.542350E-02 |
| Stage2-vs-Stage3 |
8.962200E-02 |
| Stage2-vs-Stage4 |
4.808500E-02 |
| Stage3-vs-Stage4 |
5.710800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33010003011691E-09 |
| Normal-vs-AfricanAmerican |
6.93399999973643E-07 |
| Normal-vs-Asian |
2.32750000050963E-07 |
| Caucasian-vs-AfricanAmerican |
1.113240E-01 |
| Caucasian-vs-Asian |
8.280400E-02 |
| AfricanAmerican-vs-Asian |
2.502800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.59436916394407E-12 |
| Normal-vs-Female |
1.232570E-04 |
| Male-vs-Female |
6.158600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.083400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.44969999840805E-08 |
| Normal-vs-Age(61-80Yrs) |
6.77319977882007E-10 |
| Normal-vs-Age(81-100Yrs) |
4.055600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.565600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.778400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.391400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.929200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.663000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.329200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.454100E-02 |
| Normal-vs-Grade 2 |
5.56629999999281E-05 |
| Normal-vs-Grade 3 |
1.16739951039335E-10 |
| Normal-vs-Grade 4 |
5.52299994627248E-09 |
| Grade 1-vs-Grade 2 |
8.573800E-01 |
| Grade 1-vs-Grade 3 |
7.573500E-02 |
| Grade 1-vs-Grade 4 |
8.961200E-03 |
| Grade 2-vs-Grade 3 |
1.257840E-02 |
| Grade 2-vs-Grade 4 |
1.059740E-03 |
| Grade 3-vs-Grade 4 |
1.190590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.722400E-02 |
| Normal-vs-ccB subtype |
1.63002944475465E-12 |
| ccA subtype-vs-ccB subtype |
1.62590052532607E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.79150002902418E-09 |
| Normal-vs-N1 |
5.933900E-02 |
| N0-vs-N1 |
7.064400E-01 |
|
|
